GLSI

Greenwich LifeSciences, Inc.
NasdaqCMUSDEQUITY Healthcare DELAYED
Last price
16.42
▲ 1.11 (7.22%)
MARKET ·

Price

Open
16.55
Prev close
15.31
Day high
17.34
Day low
15.54
Volume
176.06K
Market cap
$244.69M
P/E (TTM)
52W range
7.78 – 34.10

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
-0.77% +0.6%
1M
+26.38% +22.7%
3M
-38.69% -41.8%
6M
-30.71% -41.8%
YTD
-20.66% -32.9%
1Y
+39.61% +19.6%
3Y
+62.63% -11.5%
5Y

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported
Market cap$244.69M
Enterprise value$235.81M
Revenue (TTM)
Gross profit
EBITDA$-22.66M
Net income$-22.47M
EPS (TTM)$-1.59
Free cash flow$-3.34M
Total cash$8.88M
Total debt$0
Book value / share$0.36
Shares outstanding14.68M
Float7.38M
Short % of float20.14%
Dividend yield
Beta (5Y)1.45

Valuation & profitability ratios

Account required
Trailing P/E
Forward P/E-20.33
PEG ratio
Price / sales
Price / book46.43
EV / revenue
EV / EBITDA-10.41
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on equity-986.32%
Return on assets-235.98%
Debt / equity
Current ratio1.54
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

Annual · as reported
Last 4 fiscal years
Line item2025202420232022
Total revenue$0$0$0$0
Cost of revenue$0$0$0$0
Gross profit$0$0$0$0
R&D
SG&A
Operating income
Pre-tax income
Tax provision$0$0$0$0
Net income-$19.36M-$15.79M-$8.89M-$7.83M
EBIT$0$0$0$0

Earnings

History & consensus estimates
Reported vs expected · EPS
QuarterEst.ActualSurprise
Mar 2026 -0.35-0.39 -11.4%
Dec 2025 -0.32-0.58 -81.3%
Sep 2025 -0.36-0.30 +16.7%
Jun 2025 -0.24-0.30 -25.0%
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter -0.33 2 $0 0.0%
Next quarter -0.34 2 $0 0.0%
Current year -1.39 2 $0 0.0%
Next year -1.17 1 $0 0.0%

Analyst targets & ownership

Account required
Mean target$57.00
High target$69.00
Low target$45.00
Implied upside247.23%
Analyst count2
ConsensusNONE
Strong buy / Buy0 / 2
Hold0
Sell / Strong sell0 / 0
Held by insiders47.91%
Held by institutions12.25%
Institutions holding96
Free account required

Price targets, consensus spread, insider and institutional ownership.

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
Net transactions
0
Buys less sells
Sell : buy shares
Not enough filings
Insider-held shares
7.03M
Total on file

Insider transactions

Account required
DateInsiderAction SharesValueHeld
Jul 29, 26
PATEL SNEHAL
Chief Executive Officer
BUY 2.20K $29.55K Direct
Jul 27, 26
PATEL SNEHAL
Officer, Director and Beneficial Owner
BUY 1.50K $20.43K Direct
Jul 24, 26
PATEL SNEHAL
Chief Executive Officer
BUY 3.60K $47.02K Direct
Jan 13, 26
PATEL SNEHAL
Chief Executive Officer
BUY 1.80K $53.69K Direct
Jan 12, 26
PATEL SNEHAL
Chief Executive Officer
BUY 2.90K $79.87K Direct
Dec 31, 25
PATEL SNEHAL
Chief Executive Officer
BUY 4.30K $91.85K Direct
Dec 30, 25
PATEL SNEHAL
Chief Executive Officer
BUY 2.90K $63.02K Direct
Dec 18, 25
PATEL SNEHAL
Chief Executive Officer
BUY 4.10K $51.74K Direct
Nov 25, 25
PATEL SNEHAL
Chief Executive Officer
BUY 4.60K $38.50K Direct
Nov 7, 25
PATEL SNEHAL
Chief Executive Officer
BUY 10.60K $89.36K Direct
Oct 31, 25
PATEL SNEHAL
Chief Executive Officer
BUY 2.30K $21.30K Direct
Apr 25, 25
PATEL SNEHAL
Chief Executive Officer
BUY 3.60K $35.57K Direct
Apr 17, 25
PATEL SNEHAL
Chief Executive Officer
BUY 5.40K $48.49K Direct
Apr 7, 25
PATEL SNEHAL
Chief Executive Officer
BUY 3.60K $32.76K Direct
What this is, and what it is not

These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.

A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.

This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.

Free account required

Officer and director trades in their own stock, straight from Form 4 filings.

Insider holders

2 reporting
NameRelationShares heldLatest
PATEL SNEHAL
Chief Executive Officer 5.61M Purchase
THOMPSON JAYE L
Officer 264.15K Purchase

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
16.51
-0.58% from price
SMA 20
15.16
+9.96% from price
SMA 50
18.03
-7.56% from price
SMA 100
21.39
-23.27% from price
SMA 200
20.70
-19.47% from price
EMA 12
16.17
+1.54% from price
EMA 26
16.32
+0.58% from price
EMA 50
17.79
-7.72% from price
RSI (14)
51.5
Neutral
MACD (12,26,9)
-0.15
Hist 0.42
ATR (14)
1.35
8.11% of price
Realised vol 30D
99.5%
Annualised
Bollinger upper
18.15
20, 2σ
Bollinger lower
12.17
20, 2σ
50 / 200 cross
Death
18.03 vs 20.70
Trend bias
Below 200
-19.47%

Risk profile

Daily returns · 1Y window
Beta vs SPY
2.99
More volatile than market
Correlation to SPY
0.39
Loosely linked
Realised vol 30D
99.5%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-61.9%
Peak to trough
Max drawdown 5Y
-84.5%
Peak to trough
ATR 14
1.35
8.11% of price
Beta (reported)
1.45
5Y monthly, from filing

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Options analytics

Account required
Put / call volume
Put / call open interest
Positioning, not flow
Max pain
ATM implied vol
Nearest strike to spot
Skew (10% OTM)
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
Heaviest put OI

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Options chain

Account required
ExpirySpot 16.42
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.